Kyverna Therapeutics, INC. (KYTX) — DEF 14A Filings
All DEF 14A filings from Kyverna Therapeutics, INC.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Kyverna Therapeutics Files 2025 Proxy Statement
— Apr 14, 2025 Risk: low
Kyverna Therapeutics, Inc. filed its definitive proxy statement on April 14, 2025, for its annual meeting of stockholders. The filing covers the fiscal year end
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX